Drilldown: Medicines
Appearance
Medicines > classes
:
Sedative-Hypnotic
or
[[:Category:Dibenzothiazepines|Dibenzothiazepine]]
& routes:
Oral 
:
Sedative-Hypnotic
or
[[:Category:Dibenzothiazepines|Dibenzothiazepine]]
& routes:
Oral 
Use the filters below to narrow your results.
Dopamine D2 and serotonin 5-HT2A receptor antagonist'"`UNIQ--ref-0000008D-QINU`"' '"`UNIQ--vote-0000008E-QINU`"' (1) ·
Positive allosteric modulator of the GABA<sub>A</sub> receptor at the benzodiazepine binding site; increases frequency of Cl<sup>−</sup> channel opening, producing anxiolytic, sedative, hypnotic, anticonvulsant, and skeletal-muscle relaxant effects. (1)
Avoid. Benzodiazepines are associated with neonatal sedation, floppy-infant syndrome, and withdrawal; teratogenic signal weak but non-zero. Designer benzo with no safety data, assume worst-case. (1) ·
Pregnancy categories were retired by FDA in 2015. Quetiapine has reassuring active-comparator cohort data without consistent teratogenic signal; among the preferred neuroleptics when treatment is clinically necessary in pregnancy. See pregnancy_details for the full citation set. (1)
Showing below up to 2 results in range #1 to #2.

